Home » NIH to Provide Access to Exome Sequencing for Mendelian Diseases

NIH to Provide Access to Exome Sequencing for Mendelian Diseases

Aug 19, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute will provide researchers studying certain Mendelian disorders access to exome sequencing capabilities under a new four-year grant program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Sep 17, 2014

Large-scale Sequencing Studies ID Variants Associated with Lower Lipid Levels, Less Heart Disease

Premium
Jul 09, 2014

NIH to Fund New Pediatric Cardiac Genomics Centers

Feb 19, 2015

MCW Awarded $8M to Fund Rat Genome Database

Nov 05, 2014

NHLBI Awards $7.3M Contract to Moffitt, M2Gen to Coordinate Lab, Biorepository for MDS Study

Mar 26, 2014

ABRF Panelists Discuss NIH Efforts for Sharing Big Data

Sep 19, 2014

Cofactor Genomics Wins $300K Contract for Epigenetics Study of Cardiovascular Disease

The Scan

This Week in Science

In Science this week: gene regulation changes linked to human brain evolution, and more.

Seven Steps

The New York Stem Cell Foundation's Initiative on Women in Science and Engineering working group presents seven strategies to promote gender equality in the sciences.

Arsenic Adaptation

Researchers link a genetic variation to the ability to quickly process arsenic in people living in the Andes Mountains.

NIPT Tests Find Cancer in Some Pregnant Women

A small portion of pregnant women who've undergone non-invasive prenatal testing have found out from the test that they have cancer.

What's Popular?

In Clinical Sequencing

  1. Patent Pool Provides Sequenom Second Revenue Stream, Frees it to Focus on New Products

    Premium

  2. Baylor Aims to Boost Dx Rate, Discovery with 'Medical Exome,' Consenting Unsolved Cases for Research

    Premium

  3. Sequenom Posts 13 Percent Rise in Q4 Revenues, Reports Profitability for FY 2014

  4. Natera Preps Move into Cancer Dx Market as it Continues Building NIPT Capabilities

  5. AGBT: WashU Applies Genomic Testing to Predict Cancer Relapse, Drug Response, Vaccine Epitopes

    Premium

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.